Dynamic contrast enhanced MRI
Value of dynamic contrast-enhanced MRI for evaluating the cell proliferation, angiogenesis and lymphangiogenesis in lung cancer
5
Comparison of linear and nonlinear implementation of the compartmental tissue uptake model for dynamic contrast-enhanced MRI.
10
Comparison between Dynamic Contrast-Enhanced MRI and Dynamic Susceptibility Contrast MRI in Glioma Grading
8
The value of dynamic contrast-enhanced MRI in differentiating triple-negative breast cancer from other subtypes
9
Differentiating Atypical Hemangiomas and Metastatic Vertebral Lesions: The Role of T1 Weighted Dynamic Contrast Enhanced MRI
6
Measurement of pharmacokinetic parameters in histologically graded invasive breast tumours using dynamic contrast enhanced MRI
36
The Utility of Diffusion Weighted Imaging and Dynamic Contrast Enhanced MRI Techniques in Differentiation Between Benign and Malignant Uterine Masses
15
Convolutional neural networks for direct inference of pharmacokinetic parameters: Application to stroke dynamic contrast-enhanced MRI
15
Time-resolved angiography with stochastic trajectories for dynamic contrast-enhanced MRI in head and neck cancer: Are pharmacokinetic parameters affected?
9
Preoperative Prognostic Value of Dynamic Contrast Enhanced MRI–Derived Contrast Transfer Coefficient and Plasma Volume in Patients with Cerebral Gliomas
7
The added diagnostic value of dynamic contrast-enhanced MRI at 3.0 T in nonpalpable breast lesions
9
Dynamic contrast-enhanced MRI coupled with a subtraction technique is useful for treatment response evaluation of malignant melanoma hepatic metastasis
10
Automated Processing of Dynamic Contrast Enhanced MRI: Correlation of Advanced Pharmacokinetic Metrics with Tumor Grade in Pediatric Brain Tumors
6
Evaluation of Microvascular Permeability with Dynamic Contrast Enhanced MRI for the Differentiation of Primary CNS Lymphoma and Glioblastoma: Radiologic Pathologic Correlation
6
Diagnostic Accuracy of T1 Weighted Dynamic Contrast Enhanced–MRI and DWI ADC for Differentiation of Glioblastoma and Primary CNS Lymphoma
7
Comparison of semi quantitative and quantitative dynamic contrast enhanced MRI evaluations of vertebral marrow perfusion in a rat osteoporosis model
8
Quantifying Intracranial Aneurysm Wall Permeability for Risk Assessment Using Dynamic Contrast Enhanced MRI: A Pilot Study
7
T1 Weighted Dynamic Contrast Enhanced MRI as a Noninvasive Biomarker of Epidermal Growth Factor Receptor vIII Status
6
Diffusion weighted and dynamic contrast enhanced MRI of pancreatic adenocarcinoma xenografts: associations with tumor differentiation and collagen content
11